After struggling for a long time, it looks like we might be looking at better times for Hoth Therapeutics. Positive data from the initial clinical testing of the company's lead candidate is a great sign. I think there'll be more good news down the line. This definitely has major potential.
There are no replies in this thread yet. Be the first to post a reply below: